MedTrace Logo

MACE in Different Drug-Eluting Stents

NCT06470529 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4159

Last updated 2024-06-27

No results posted yet for this study

Summary

In this retrospective cohort study, all patients from Iranian registry were recruited and follow up after 5 years were recorded for MACE, and its relation to type and demographic data were evaluated

Conditions

Interventions

DEVICE

drug eluting stents

different types of drug eluting stents

Sponsors & Collaborators

  • Shiraz University of Medical Sciences

    lead OTHER

Eligibility

Min Age
36 Years
Max Age
82 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2021-02-01
Completion
2021-07-01

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06470529 on ClinicalTrials.gov